Intranuovo, F., Brunetti, L., Delre, P., Mangiatordi, G., Stefanachi, A., Laghezza, A., . . . Contino, M. (2023). Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase.
Citación estilo ChicagoIntranuovo, F., et al. Development of N-(1-Adamantyl)benzamides As Novel Anti-Inflammatory Multitarget Agents Acting As Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase. 2023.
Cita MLAIntranuovo, F., et al. Development of N-(1-Adamantyl)benzamides As Novel Anti-Inflammatory Multitarget Agents Acting As Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase. 2023.
Precaución: Estas citas no son 100% exactas.